Most popular articles
Everything About Peaches. Clemson University Cooperative Extension Service Everything About Peaches Website: whether you are a professional or backyard peach...
Mission Statement. For the sake of mankind and the world as a whole a further increase of the sustainability...
Newsletter 9: July 2013 - Temperate Fruits in the Tropics and Subtropics. Download your copy of the Working Group Temperate...
USA Walnut varieties. The Walnut Germplasm Collection of the University of California, Davis (USA). A description of the Collection and a History...
China Walnut varieties.

Articles

HEALTH PROMOTING FOODS: RESEARCHING THE PROCESSED TOMATO

Article number
823_24
Pages
165 – 168
Language
English
Abstract
Less then 20% of the published human studies literature on processed tomatoes focuses on heart disease outcomes.
Of this work, most target oxidative stress endpoints, as tomatoes are a rich source of lycopene, a documented powerful anti-oxidant compound.
In addition to lycopene however; tomatoes contain a number of bioactive essential and non-essential compounds.
Therefore, the action of tomatoes when consumed regularly may provide a much broader scope of health promoting properties.
We hypothesize that the complex mixture of bioactive compounds in tomato will provide anti-thrombotic protection as well as improve vascular relaxation responses, in addition to anti-oxidant activity in overweight men and women.
The study approach utilizes an acute- and chronic- phase study paradigm to compare changes in fasting and postprandial clinical endpoints after single- and long-term exposure of processed tomato products vs. non-tomato products.
Sixty men and women recruited at 2 research sites in the U.S. will be randomized, after 3 weeks run-in, to 1 of 2 treatment arms for 6 weeks consuming either processed tomato products daily or non-tomato products matched for energy, sodium and sugar content.
During run-in and at the end of the 6 weeks treatment, a subset of subjects will also participate in a 6 h postprandial study with defined test meals and intervals for blood sampling and flow-medicated dilation (FMD) assessment.
Clinical efficacy will be evaluated on platelet aggregation, FMD, and select metabolic-, oxidative- and inflammatory- stress biomarkers.

Publication
Authors
B. Burton-Freeman
Keywords
Full text
Online Articles (33)
G. Tommonaro | A. Poli | R. De Prisco | B. Nicolaus
A. Battilani | F. Plauborg | M.N. Andersen | M. Andersen | A. Schweitzer | M. Steiner | L. Sandei | S. Gola | A. Dalsgaard | A. Forslund | W. Klopmann | D. Solimando
A. Battilani | D. Solimando | F.L. Plauborg | M.N. Andersen | C.R. Jensen | L. Sandei
M. Cámara | M.C. Sánchez-Mata | V. Fernández-Ruiz | G. Piera
M.O. Bildstein | J. García | M. Faraldi | S. Colvine
M.M.A. Khan | G. Bhardwaj | M. Naeem | Moinuddin | F. Mohammad | M. Singh | S. Nasir | M. Idrees
S. Porretta | G. Poli | G. Dellapina | V. Moscatelli | L. Palmieri | P. Bondioli